期刊文献+

p300RNA干扰慢病毒载体的构建及其在CNE-2细胞中的表达

Construction of a Lentivirus Interfering Vector Carrying p300Gene with RNA Interfering and Its Expression in the CNE-2 Cells
下载PDF
导出
摘要 目的构建p300基因RNA干扰慢病毒载体获得稳定感染的人鼻咽癌CNE-2细胞株,以观察CNE-2细胞中p300的表达及其功能。方法设计p300基因特异性RNA干扰靶序列,与经Hpa I和Xho I酶切后的载体连接,产生重组慢病毒质粒p LL-GFP-Puro-shp300,筛选阳性克隆,测序鉴定,与慢病毒包装载体共转染293T细胞,包装产生慢病毒,对病毒滴度和感染效率进行检测。结果 p LL-GFP-Puro-shp300慢病毒RNA干扰载体经酶切和测序鉴定证实准确连接测序正确,且包装出来的病毒纯化后滴度达107TU·m L-1。RT-q PCR、Western blot结果显示感染后p300 mRNA及蛋白水平显著下降,证明重组慢病毒对CNE-2细胞p300基因表达有明显沉默作用。结论成功构建靶向p300基因RNA干扰慢病毒载体,为进一步研究p300在鼻咽癌发生过程中的作用奠定基础。 Objective To construct a lentiviral vector carrying p300 gene with RNA interfering, and to establish human nasopharyngeal carcinoma cells with stably inhibited p300. Methods Two pairs of small hairpin RNA specific for p300 were designed, synthesized and cloned into the pLL3.7-GFP-Puro vector. Then, the lentivirual plasmid was transfected with the other two packaging plasmids into 293T cells to product and amplify lentivirus. After the infection of lentivirus mediated siRNA-p300, the mRNA and protein expression of p300 were observed. Results The lentivirus vector of siRNA-p300 was constructed successfully. The virus titres were above 10^7 TU ·mL^-1. pLL-GFP-Puro-shp300 was effective to inhibit p300 expression in mRNA and protein levels of CNE-2 cells. Conclusion A lentiviral vector carrying p300 gene with RNA interfering is successfully constructed. This study lays a foundation for further study of mechanisms of p300 in the nasopharyngeal carcinoma.
出处 《肿瘤基础与临床》 2015年第6期464-468,共5页 journal of basic and clinical oncology
基金 广州医科大学大学生科技创新项目(编号:2013A002) 广州市医药卫生科技项目(编号:20141A011092)
关键词 P300 鼻咽癌 慢病毒载体 p300 nasopharyngeal carcinoma lentiviral vector
  • 相关文献

参考文献4

二级参考文献31

  • 1Michalis V Karamouzis,Panagiotis A Konstantinopoulos,Athanasios G Papavassiliou.Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis[J].Cell Research,2007,17(4):324-332. 被引量:6
  • 2Manjunath N,Wu H,Subramanya S,et al.Lentiviral delivery of short hairpin RNAs[J].Adv Drug Deliv Rev,2009,61(9):732-745.
  • 3Hacein Bey Abina S,Garrigue A,Wang GP,et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1[J].J Clin Invest,2008,118(9):3132-3142.
  • 4Gou D,Weng T,Wang Y,et al.A novel approach for the construction of multiple shRNA expression vectors[J].J Gene Med,2007,9(9):751-763.
  • 5Liu YP,Haasnoot J,ter Brake O,et al.Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron[J].Nucleic Acids Res,2008,36(9):2811-2824.
  • 6De Maria R,Miretti S,Iussich S,et al.met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma[J].J Pathol,2009,218(3):399-408.
  • 7Chen D,Huang H,Pan C,et al.Antitumor effects of targeting hTERT lentivirus-mediated RNA interference against KB cell lines[J].Oncol Res,2009,17(11-12):621-630.
  • 8Marangoni F,Bosticardo M,Charrier S,et al.Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models[J].Mol Ther,2009,17(6):1073-1082.
  • 9Rawls AS,Gregory AD,Woloszynek JR,et al.Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential[J].Blood,2007,110(7):2414-2422.
  • 10Ye X,Liu T,Gong Y,et al.Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1[J].Leuk Res,2009,33(8):1114-1119.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部